Visualization and quantification of dynamic STAT3 homodimerization in living cells using homoFluoppi
Yusuke Okada(University of Shizuoka), Akira Asai(University of Shizuoka)
Cited by 11
Related Papers
Inhibition of STAT3 by Anticancer Drug Bendamustine
|PLoS ONE|2017|16
Discovery of a New STAT3 Inhibitor Acting on the Linker Domain
|Biological and Pharmaceutical Bulletin|2019|13
Efficacy of combination treatment using YHO-1701, an orally active STAT3 inhibitor, with molecular-targeted agents on cancer cell lines
|Scientific Reports|2021|12
Tributylhexadecylphosphonium Bromide, a Novel Nuclear Factor of Activated T Cells Signaling Inhibitor, Blocks Interleukin-2 Induction Associated with Inhibition of p70 Ribosomal Protein S6 Kinase Phosphorylation
|Biological and Pharmaceutical Bulletin|2012|4
Combined therapeutic effect of YHO-1701 with PD-1 blockade is dependent on natural killer cell activity in syngeneic mouse models
|Cancer Immunology Immunotherapy|2023|4